Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0IB8C
|
|||
Former ID |
DNC003677
|
|||
Drug Name |
6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one
|
|||
Synonyms |
CHEMBL72368; 6-tosylpyridazin-3(2H)-one; BDBM16447; ZINC11536215; AKOS015830955; AKOS001773373; MCULE-5757912617; CCG-126887; 6-phenylsulfonylpyridazin-2H-3-one, 9; 99985-09-8; Phenyl-Substituted Sulfonylpyridazinone, 8i; 3(2H)-Pyridazinone, 6-[(4-methylphenyl)sulfonyl]-; F6548-0368
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H10N2O3S
|
|||
Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)C2=NNC(=O)C=C2
|
|||
InChI |
1S/C11H10N2O3S/c1-8-2-4-9(5-3-8)17(15,16)11-7-6-10(14)12-13-11/h2-7H,1H3,(H,12,14)
|
|||
InChIKey |
SGMDNRFRSNYBCA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Aldose reductase (AKR1B1) | Target Info | Inhibitor | [1] |
BioCyc | Methylglyoxal degradation III | |||
Acetone degradation I (to methylglyoxal) | ||||
KEGG Pathway | Pentose and glucuronate interconversions | |||
Fructose and mannose metabolism | ||||
Galactose metabolism | ||||
Glycerolipid metabolism | ||||
Metabolic pathways | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway | ||||
Pathwhiz Pathway | Fructose and Mannose Degradation | |||
Pyruvate Metabolism | ||||
Pterine Biosynthesis | ||||
Glycerolipid Metabolism | ||||
Galactose Metabolism | ||||
WikiPathways | Metapathway biotransformation | |||
Polyol Pathway | ||||
Metabolism of steroid hormones and vitamin D |
References | Top | |||
---|---|---|---|---|
REF 1 | A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3... J Med Chem. 2005 Oct 6;48(20):6326-39. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.